Hallux Terbinafine Subungual Gel
- Generic Name
- Hallux Terbinafine Subungual Gel
To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis
Phase 2
Active, not recruiting
- Conditions
- Onychomycosis of Toenail
- Interventions
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Hallux, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05135910
- Locations
- 🇺🇸
OrthoArizona - East Valley Foot & Ankle Specialists, Mesa, Arizona, United States
🇺🇸Front Range Foot and Ankle Clinic, Parker, Colorado, United States
🇺🇸Oregon Dermatology & Research Center, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath